Canada Markets open in 3 hrs 59 mins

PharmaTher Holdings Ltd. (PHRRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1065+0.0002 (+0.18%)
At close: 03:53PM EDT

PharmaTher Holdings Ltd.

82 Richmond Street East
Toronto, ON M5C 1P1
Canada
888 846 3171
https://www.pharmather.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Fabio ChianelliCEO & Chairman133.09kN/A1978
Mr. Carmelo Marrelli ACIS, B.Comm., CA, CGA, CPAChief Financial Officer68.05kN/A1971
Mr. Andrew ToddCorp. Sec.N/AN/A1958
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine injectables/infusions, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase II clinical trial for treating depression; and Ketamine Pump, which is in Phase II clinical trial to treat complex regional pain syndrome, metal health, neurological, and pain disorders. In addition, the company engages in the development of PHARMAPATCH, a microneedle patch to deliver psychedelics. PharmaTher Holdings Ltd has collaboration agreements with LTS Lohmann Therapie-Systeme AG for developing Ketamin microneedle patch; Alcami Corporation to develop Ketamin injectables/infusions; BioRAE, Inc. for the development of Ketamin pumps; and Revive Therapeutics Ltd. to develop psilocybin microneedle patch. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

Corporate Governance

PharmaTher Holdings Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.